Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial

Table 1 Preoperative characteristics

Patient	Group	Age	Sex	BMI	Coronary risk factors	NYHA classification
Case 1	ADSC	60	Male	23	HL, smoking	2
Case 2	ADSC	69	Male	18	HT, HL, smoking	3
Case 3	ADSC	62	Male	24	HT, smoking	2
Case 4	Placebo	74	Male	26	DM, HT, HL, smoking	3
Case 5	Placebo	64	Male	22	HL, smoking	2
Case 6	Placebo	72	Male	24	Smoking	3

ADSC adipose-derived stem cell, BMI body mass index, HL hyperlipidemia, HT hypertension, DM diabetes mellitus, NYHA New York Heart Association

ISSN: 1479-5876